Meta10-TIL

Metabolically armed tumor-infiltrating lymphocytes

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Meta10-TIL, covering 2025-09-15 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors [EARLY_Phase 1]

See pricing